Neurology

Management of myasthenia gravis.

Semin Neurol. 2004 Mar;24(1):41-8.
 
Saperstein DS, Barohn RJ.

Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.

Although once a severe and often fatal illness, myasthenia gravis can now be well managed with several relatively safe and effective therapies. Management involves a graded approach, beginning with cholinesterase inhibitors for mild symptoms and advancing to immunomodulating medications for more severe weakness. There are several immunomodulating agents from which to choose; selection is based largely on time to clinical effect and adverse effects. This review will discuss the selection and use of therapies for patients with myasthenia gravis.

Publication Types:
  • Review
  • Review, Tutorial

PMID: 15229791 [PubMed - indexed for MEDLINE]

 

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100